Long-term outcome after drug-eluting stent implantation in comparison with bare metal stents: A single centre experience

Clinical Research in Cardiology

Volumn 100, Issue 3, 2011, Pages 191-200

  Tentzeris, Ioannis ^a   Jarai, Rudolf ^a   Farhan, Serdar ^a   Wojta, Johann ^b   Schillinger, Martin ^a   Geppert, Alexander ^a   Nürnberg, Michael ^a   Unger, Gerhard ^a   Huber, Kurt ^a  

^a WILHELMINEN HOSPITAL   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Bare metal stents; Drug eluting stents; Mortality; Target vessel revascularization

Indexed keywords

ACUTE CORONARY SYNDROME; ADULT; AGE; AGED; ARTICLE; BARE METAL STENT; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE REGISTRY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; HYPERLIPIDEMIA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PROPENSITY SCORE; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; REVASCULARIZATION;

AGED; CORONARY DISEASE; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RETREATMENT; RISK FACTORS; STENTS; TREATMENT OUTCOME;

EID: 79954584811     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-010-0228-5     Document Type: Article

References (63)

1. The global use of strategies to open occluded coronary arteries in acute coronary syndromes (GUSTO IIb) Angioplasty Substudy Investigators (1997) A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med 336:1621-1628
2. J Al Suwaidi DR Holmes Jr AM Salam R Lennon PB Berger 2004 Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty Am Heart J 147 815 822 10.1016/j.ahj.2003.11.025 15131536 (Pubitemid 38880987)
3. PW Serruys P de Jaegere F Kiemeneij C Macaya W Rutsch G Heyndrickx H Emanuelsson J Marco V Legrand P Materne, et al. 1994 A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group N Engl J Med 331 489 495 1:STN:280:DyaK2czhs1anuw%3D%3D 10.1056/NEJM199408253310801 8041413 (Pubitemid 24256751)
4. A Betriu M Masotti A Serra J Alonso F Fernandez-Aviles F Gimeno T Colman J Zueco JL Delcan E Garcia J Calabuig 1999 Randomized comparison of coronary stent implantation and balloon angioplasty in the treatment of de novo coronary artery lesions (START): a four-year follow-up J Am Coll Cardiol 34 1498 1506 1:STN:280:DC%2BD3c%2Fhslylsw%3D%3D 10.1016/S0735-1097(99)00366-6 10551699 (Pubitemid 29528664)
5. MP Savage DL Fischman R Rake MB Leon RA Schatz I Penn M Nobuyoshi J Moses J Hirshfeld R Heuser D Baim M Cleman J Brinker S Gebhardt S Goldberg 1998 Efficacy of coronary stenting versus balloon angioplasty in small coronary arteries. Stent Restenosis Study (STRESS) Investigators J Am Coll Cardiol 31 307 311 1:STN:280:DyaK1c7it1Cjtg%3D%3D 10.1016/S0735-1097(97)00511-1 9462572 (Pubitemid 28153448)
6. R Erbel M Haude HW Hopp D Franzen HJ Rupprecht B Heublein K Fischer P de Jaegere P Serruys W Rutsch P Probst 1998 Coronary-artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty. Restenosis Stent Study Group N Engl J Med 339 1672 1678 1:STN:280:DyaK1M%2FktFWkug%3D%3D 10.1056/NEJM199812033392304 9834304 (Pubitemid 28550692)
7. WD Weaver MA Reisman JJ Griffin CE Buller PP Leimgruber T Henry C D'Haem VL Clark JS Martin DJ Cohen N Neil NR Every 2000 Optimum percutaneous transluminal coronary angioplasty compared with routine stent strategy trial (OPUS-1): a randomised trial Lancet 355 2199 2203 1:STN:280: DC%2BD3czjslOnsw%3D%3D 10.1016/S0140-6736(00)02403-X 10881893 (Pubitemid 30394327)
8. DL Fischman MB Leon DS Baim RA Schatz MP Savage I Penn K Detre L Veltri D Ricci M Nobuyoshi, et al. 1994 A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators N Engl J Med 331 496 501 1:STN:280:DyaK2czhs1amsg%3D%3D 10.1056/NEJM199408253310802 8041414 (Pubitemid 24256752)
9. JW Moses MB Leon JJ Popma PJ Fitzgerald DR Holmes C O'Shaughnessy RP Caputo DJ Kereiakes DO Williams PS Teirstein JL Jaeger RE Kuntz 2003 Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N Engl J Med 349 1315 1323 1:CAS:528:DC%2BD3sXnvVGitrc%3D 10.1056/NEJMoa035071 14523139 (Pubitemid 37186209)
10. MC Morice PW Serruys JE Sousa J Fajadet E Ban Hayashi M Perin A Colombo G Schuler P Barragan G Guagliumi F Molnar R Falotico 2002 A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization N Engl J Med 346 1773 1780 1:CAS:528:DC%2BD38Xkt1Olsbw%3D 10.1056/NEJMoa012843 12050336 (Pubitemid 34586912)
11. GW Stone SG Ellis DA Cox J Hermiller C O'Shaughnessy JT Mann M Turco R Caputo P Bergin J Greenberg JJ Popma ME Russell 2004 A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease N Engl J Med 350 221 231 1:CAS:528:DC%2BD2cXkvVKmtQ%3D%3D 10.1056/NEJMoa032441 14724301 (Pubitemid 38067635)
12. GW Stone SG Ellis DA Cox J Hermiller C O'Shaughnessy JT Mann M Turco R Caputo P Bergin J Greenberg JJ Popma ME Russell 2004 One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial Circulation 109 1942 1947 1:CAS:528:DC%2BD2cXjtFOmt74%3D 10.1161/01.CIR.0000127110.49192.72 15078803 (Pubitemid 38544483)
13. MC Morice PW Serruys P Barragan C Bode GA Van Es HP Stoll D Snead L Mauri DE Cutlip E Sousa 2007 Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial J Am Coll Cardiol 50 1299 1304 1:CAS:528:DC%2BD2sXhtFSlurfF 10.1016/j.jacc.2007.06.029 17903626 (Pubitemid 47454687)
14. G Weisz MB Leon DR Holmes Jr DJ Kereiakes MR Clark BM Cohen SG Ellis P Coleman C Hill C Shi DE Cutlip RE Kuntz JW Moses 2006 Two-year outcomes after sirolimus-eluting stent implantation: results from the sirolimus-eluting stent in de novo native coronary lesions (SIRIUS) trial J Am Coll Cardiol 47 1350 1355 1:CAS:528:DC%2BD28XjtFGgurc%3D 10.1016/j.jacc.2005.11.077 16580520
15. AT Ong RT van Domburg J Aoki K Sonnenschein PA Lemos PW Serruys 2006 Sirolimus-eluting stents remain superior to bare-metal stents at two years: medium-term results from the rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital (RESEARCH) Registry J Am Coll Cardiol 47 1356 1360 1:CAS:528:DC%2BD28XjtFGgu74%3D 10.1016/j.jacc.2005.05.102 16580521
16. M Valgimigli G Campo C Arcozzi P Malagutti R Carletti F Ferrari D Barbieri G Parrinello G Percoco R Ferrari 2007 Two-year clinical follow-up after sirolimus-eluting versus bare-metal stent implantation assisted by systematic glycoprotein IIb/IIIa Inhibitor Infusion in patients with myocardial infarction: results from the STRATEGY study J Am Coll Cardiol 50 138 145 1:CAS:528:DC%2BD2sXnsFymu7Y%3D 10.1016/j.jacc.2007.04.029 17616297 (Pubitemid 47002182)
17. PA Lemos F Saia SH Hofma J Daemen AT Ong CA Arampatzis A Hoye E McFadden G Sianos PC Smits WJ van der Giessen P de Feyter RT van Domburg PW Serruys 2004 Short- and long-term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarction J Am Coll Cardiol 43 704 708 10.1016/j.jacc.2003.12.022 14975486 (Pubitemid 38229548)
18. GJ Laarman MJ Suttorp MT Dirksen L van Heerebeek F Kiemeneij T Slagboom LR van der Wieken JG Tijssen BJ Rensing M Patterson 2006 Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention N Engl J Med 355 1105 1113 1:CAS:528:DC%2BD28XpsFKksr0%3D 10.1056/NEJMoa062598 16971717 (Pubitemid 44394917)
19. A Kastrati A Dibra C Spaulding GJ Laarman M Menichelli M Valgimigli E Di Lorenzo C Kaiser I Tierala J Mehilli M Seyfarth O Varenne MT Dirksen G Percoco A Varricchio U Pittl M Syvanne MJ Suttorp R Violini A Schomig 2007 Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction Eur Heart J 28 2706 2713 10.1093/eurheartj/ ehm402 17901079 (Pubitemid 350139205)
20. D Baumgart V Klauss F Baer F Hartmann H Drexler W Motz H Klues S Hofmann W Volker T Pfannebecker HP Stoll G Nickenig 2007 One-year results of the SCORPIUS study: a German multicenter investigation on the effectiveness of sirolimus-eluting stents in diabetic patients J Am Coll Cardiol 50 1627 1634 10.1016/j.jacc.2007.07.035 17950142 (Pubitemid 47562680)
21. M Menichelli A Parma E Pucci R Fiorilli F De Felice M Nazzaro A Giulivi D Alborino A Azzellino R Violini 2007 Randomized trial of sirolimus-eluting stent versus bare-metal stent in acute myocardial infarction (SESAMI) J Am Coll Cardiol 49 1924 1930 1:CAS:528:DC%2BD2sXlt1amt7c%3D 10.1016/j.jacc.2007.01.081 17498576 (Pubitemid 46694284)
22. GW Stone AJ Lansky SJ Pocock BJ Gersh G Dangas SC Wong B Witzenbichler G Guagliumi JZ Peruga BR Brodie D Dudek M Mockel A Ochala A Kellock H Parise R Mehran 2009 Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction N Engl J Med 360 1946 1959 1:CAS:528:DC%2BD1MXlsFCqtL8%3D 10.1056/NEJMoa0810116 19420364
23. C Spaulding MC Morice B Lancelin S El Haddad E Lepage S Bataille JP Tresca X Mouranche S Fosse M Monchi N de Vernejoul 2006 Is the volume-outcome relation still an issue in the era of PCI with systematic stenting? Results of the greater Paris area PCI registry Eur Heart J 27 1054 1060 10.1093/eurheartj/ehi843 16569652
24. SS Brar MB Leon GW Stone R Mehran JW Moses SK Brar G Dangas 2009 Use of drug-eluting stents in acute myocardial infarction: a systematic review and meta-analysis J Am Coll Cardiol 53 1677 1689 10.1016/j.jacc.2009.03.013 19406344
25. E Di Lorenzo R Sauro A Varricchio G Carbone G Cortese M Capasso T Lanzillo F Manganelli C Mariello F Siano MR Pagliuca G Stanco G Rosato G De Luca 2009 Long-Term outcome of drug-eluting stents compared with bare metal stents in ST-segment elevation myocardial infarction: results of the paclitaxel- or sirolimus-eluting stent versus bare metal stent in primary angioplasty (PASEO) randomized trial Circulation 120 964 972 1:CAS:528:DC%2BD1MXht1WntbbM 10.1161/CIRCULATIONAHA.108.830372 19720939
26. HK Win AE Caldera K Maresh J Lopez CS Rihal MA Parikh JF Granada S Marulkar D Nassif DJ Cohen NS Kleiman 2007 Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents Jama 297 2001 2009 1:CAS:528:DC%2BD2sXltFyks7o%3D 10.1001/jama.297.18.2001 17488965 (Pubitemid 46740352)
27. N Beohar CJ Davidson KE Kip L Goodreau HA Vlachos SN Meyers KH Benzuly JD Flaherty MJ Ricciardi CL Bennett DO Williams 2007 Outcomes and complications associated with off-label and untested use of drug-eluting stents Jama 297 1992 2000 1:CAS:528:DC%2BD2sXltFyks70%3D 10.1001/jama.297.18.1992 17488964 (Pubitemid 46740351)
28. AJ Nordmann M Briel HC Bucher 2006 Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis Eur Heart J 27 2784 2814 1:CAS:528:DC%2BD2sXptValug%3D%3D 10.1093/eurheartj/ehl282 17020889 (Pubitemid 44871464)
29. B Lagerqvist SK James U Stenestrand J Lindback T Nilsson L Wallentin 2007 Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden N Engl J Med 356 1009 1019 1:CAS:528:DC%2BD2sXisFKrsLY%3D 10.1056/NEJMoa067722 17296822 (Pubitemid 46376801)
30. S Silber P Albertsson FF Aviles PG Camici A Colombo C Hamm E Jorgensen J Marco JE Nordrehaug W Ruzyllo P Urban GW Stone W Wijns 2005 Guidelines for percutaneous coronary interventions. The task force for percutaneous coronary interventions of the European Society of Cardiology Eur Heart J 26 804 847 10.1093/eurheartj/ehi564 15769784
31. WK Laskey CW Yancy WH Maisel 2007 Thrombosis in coronary drug-eluting stents: report from the meeting of the Circulatory System Medical Devices Advisory Panel of the Food and Drug Administration Center for Devices and Radiologic Health, December 7-8, 2006 Circulation 115 2352 2357 10.1161/CIRCULATIONAHA.107.688416 17470710 (Pubitemid 46685904)
32. J Daemen S Tanimoto HM Garcia-Garcia N Kukreja M van de Sande G Sianos PP de Jaegere RT van Domburg PW Serruys 2007 Comparison of three-year clinical outcome of sirolimus- and paclitaxel-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction (from the RESEARCH and T-SEARCH registries) Am J Cardiol 99 1027 1032 1:CAS:528:DC%2BD2sXktF2ms7k%3D 10.1016/j.amjcard.2006.11.070 17437722 (Pubitemid 46560473)
33. C Spaulding J Daemen E Boersma DE Cutlip PW Serruys 2007 A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents N Engl J Med 356 989 997 1:CAS:528:DC%2BD2sXisFKnur4%3D 10.1056/NEJMoa066633 17296825 (Pubitemid 46376799)
34. JV Tu J Bowen M Chiu DT Ko PC Austin Y He R Hopkins JE Tarride G Blackhouse C Lazzam EA Cohen R Goeree 2007 Effectiveness and safety of drug-eluting stents in Ontario N Engl J Med 357 1393 1402 1:CAS:528: DC%2BD2sXhtFeisLvE 10.1056/NEJMoa071076 17914040 (Pubitemid 47541971)
35. GW Stone JW Moses SG Ellis J Schofer KD Dawkins MC Morice A Colombo E Schampaert E Grube AJ Kirtane DE Cutlip M Fahy SJ Pocock R Mehran MB Leon 2007 Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents N Engl J Med 356 998 1008 1:CAS:528:DC%2BD2sXisFKmu7o%3D 10.1056/NEJMoa067193 17296824 (Pubitemid 46376800)
36. H Kelbaek L Thuesen S Helqvist P Clemmensen L Klovgaard A Kaltoft B Andersen H Thuesen T Engstrom HE Botker K Saunamaki LR Krusell E Jorgensen HH Hansen EH Christiansen J Ravkilde L Kober KF Kofoed CJ Terkelsen JF Lassen 2008 Drug-eluting versus bare metal stents in patients with st-segment-elevation myocardial infarction: eight-month follow-up in the drug elution and distal protection in acute myocardial infarction (DEDICATION) trial Circulation 118 1155 1162 1:CAS:528:DC%2BD1cXhtVOiurjL 10.1161/CIRCULATIONAHA.107.758698 18725489
37. C Stettler S Wandel S Allemann A Kastrati MC Morice A Schomig ME Pfisterer GW Stone MB Leon JS de Lezo JJ Goy SJ Park M Sabate MJ Suttorp H Kelbaek C Spaulding M Menichelli P Vermeersch MT Dirksen P Cervinka AS Petronio AJ Nordmann P Diem B Meier M Zwahlen S Reichenbach S Trelle S Windecker P Juni 2007 Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis Lancet 370 937 948 1:CAS:528: DC%2BD2sXhtVeqsL7E 10.1016/S0140-6736(07)61444-5 17869634 (Pubitemid 47393576)
38. A Kastrati J Mehilli J Pache C Kaiser M Valgimigli H Kelbaek M Menichelli M Sabate MJ Suttorp D Baumgart M Seyfarth ME Pfisterer A Schomig 2007 Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents N Engl J Med 356 1030 1039 1:CAS:528:DC%2BD2sXisFOjurY%3D 10.1056/NEJMoa067484 17296823 (Pubitemid 46376803)
39. DO Williams JD Abbott KE Kip 2006 Outcomes of 6906 patients undergoing percutaneous coronary intervention in the era of drug-eluting stents: report of the DEScover Registry Circulation 114 2154 2162 10.1161/CIRCULATIONAHA.106. 667915 17060386 (Pubitemid 44747896)
40. M Pfisterer HP Brunner-La Rocca P Rickenbacher P Hunziker C Mueller F Nietlispach G Leibundgut F Bader C Kaiser 2009 Long-term benefit-risk balance of drug-eluting vs. bare-metal stents in daily practice: does stent diameter matter? Three-year follow-up of BASKET Eur Heart J 30 16 24 10.1093/eurheartj/ ehn516 19033260
41. D Sibbing T Morath J Stegherr S Braun W Vogt M Hadamitzky A Schomig A Kastrati N von Beckerath 2009 Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel Thromb Haemost 101 714 719 1:CAS:528:DC%2BD1MXltVertbs%3D 19350116
42. P Ortolani M Balducelli P Marzaroli G Piovaccari A Menozzi V Guiducci P Sangiorgio F Tarantino G Geraci F Castriota S Tondi F Saia RM Cooke P Guastaroba R Grilli A Marzocchi A Maresta 2008 Two-year clinical outcomes with drug-eluting stents for diabetic patients with de novo coronary lesions: results from a real-world multicenter registry Circulation 117 923 930 1:CAS:528:DC%2BD1cXhsFCru7o%3D 10.1161/CIRCULATIONAHA.107.730416 18250265 (Pubitemid 351272590)
43. PG Steg J Lopez-Sendon E Lopez de Sa SG Goodman JM Gore FA Anderson Jr D Himbert J Allegrone F Van de Werf 2007 External validity of clinical trials in acute myocardial infarction Arch Intern Med 167 68 73 10.1001/archinte.167.1.68 17210880 (Pubitemid 46072409)
44. AJ Kirtane A Gupta S Iyengar JW Moses MB Leon R Applegate B Brodie E Hannan K Harjai LO Jensen SJ Park R Perry M Racz F Saia JV Tu R Waksman AJ Lansky R MehranStone GW GW Stone 2009 Safety and efficacy of drug-eluting and bare metal stents. Comprehensive meta-analysis of randomized trials and observational studies Circulation 119 3198 3206 1:CAS:528:DC%2BD1MXnsFyiurc%3D 10.1161/CIRCULATIONAHA.108.826479 19528338
45. LO Jensen M Maeng A Kaltoft P Thayssen HH Hansen M Bottcher JF Lassen LR Krussel K Rasmussen KN Hansen L Pedersen SP Johnsen HT Soerensen L Thuesen 2007 Stent thrombosis, myocardial infarction, and death after drug-eluting and bare-metal stent coronary interventions J Am Coll Cardiol 50 463 470 1:CAS:528:DC%2BD2sXot1ymt7g%3D 10.1016/j.jacc.2007.06.002 17662400 (Pubitemid 47088133)
46. L Mauri TS Silbaugh RE Wolf K Zelevinsky A Lovett Z Zhou FS Resnic SL Normand 2008 Long-term clinical outcomes after drug-eluting and bare-metal stenting in Massachusetts Circulation 118 1817 1827 10.1161/CIRCULATIONAHA.108. 781377 18852368
47. BL van der Hoeven SS Liem JW Jukema N Suraphakdee H Putter J Dijkstra DE Atsma M Bootsma K Zeppenfeld PV Oemrawsingh EE van der Wall MJ Schalij 2008 Sirolimus-eluting stents versus bare-metal stents in patients with ST-segment elevation myocardial infarction: 9-month angiographic and intravascular ultrasound results and 12-month clinical outcome results from the MISSION! Intervention Study J Am Coll Cardiol 51 618 626 10.1016/j.jacc.2007.09.056 18261680 (Pubitemid 351186867)
48. PittlU KC HP Brunner-La Rocca P Hunziker AZ Linka S Osswald PT Buser ME Pfisterer on behalf of the BASKET Investigators 2006 Safety and efficacy of drug eluting stents versus bare metal stents in primary angioplasty of patients with acute ST-elevation myocardial infarction - a prospective randomized study Eur Heart J 27 650
49. LS de Diaz la Llera S Ballesteros J Nevado M Fernandez M Villa A Sanchez G Retegui D Garcia A Martinez 2007 Sirolimus-eluting stents compared with standard stents in the treatment of patients with primary angioplasty Am Heart J 154 164 e1 164 e6
50. V Pasceri G Patti G Speciale C Pristipino G Richichi G Di Sciascio 2007 Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarction Am Heart J 153 749 754 1:CAS:528: DC%2BD2sXksVOru7Y%3D 10.1016/j.ahj.2007.02.016 17452148 (Pubitemid 46602146)
51. L Mauri TS Silbaugh P Garg RE Wolf K Zelevinsky A Lovett MR Varma Z Zhou SL Normand 2008 Drug-eluting or bare-metal stents for acute myocardial infarction N Engl J Med 359 1330 1342 1:CAS:528:DC%2BD1cXhtFKjsb3F 10.1056/NEJMoa0801485 18815397
52. EVA Di Lorenzo T Lanzillo R Sauro GM Cianciulli F Manganelli C Mariello F Siano MP Pagliuca G Stanco G Rosato 2005 Paclitaxel and sirolimus stent implantation in patients with acute myocardial infarction Circulation 112 U538
53. NK Wenger 2003 Coronary heart disease: the female heart is vulnerable Prog Cardiovasc Dis 46 199 229 10.1016/j.pcad.2003.08.003 14685940 (Pubitemid 38028610)
54. P Garg SL Normand TS Silbaugh RE Wolf K Zelevinsky A Lovett MR Varma Z Zhou L Mauri 2008 Drug-eluting or bare-metal stenting in patients with diabetes mellitus: results from the Massachusetts Data Analysis Center Registry Circulation 118 2277 2285 1:CAS:528:DC%2BD1cXhtlyks7bF 10.1161/CIRCULATIONAHA. 108.820159 19001019 (7p following 2285)
55. L Mauri WH Hsieh JM Massaro KK Ho R D'Agostino DE Cutlip 2007 Stent thrombosis in randomized clinical trials of drug-eluting stents N Engl J Med 356 1020 1029 1:CAS:528:DC%2BD2sXisFKqtbc%3D 10.1056/NEJMoa067731 17296821 (Pubitemid 46376802)
56. AE Rodriguez AO Maree J Mieres D Berrocal L Grinfeld C Fernandez-Pereira V Curotto A Rodriguez-Granillo W O'Neill IF Palacios 2007 Late loss of early benefit from drug-eluting stents when compared with bare-metal stents and coronary artery bypass surgery: 3 years follow-up of the ERACI III registry Eur Heart J 28 2118 2125 10.1093/eurheartj/ehm297 17656352 (Pubitemid 47517450)
57. P Wenaweser J Daemen M Zwahlen R van Domburg P Juni S Vaina G Hellige K Tsuchida C Morger E Boersma N Kukreja B Meier PW Serruys S Windecker 2008 Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study J Am Coll Cardiol 52 1134 1140 1:CAS:528:DC%2BD1cXhtFersr7J 10.1016/j.jacc.2008.07.006 18804739
58. T Kimura T Morimoto Y Nakagawa T Tamura K Kadota H Yasumoto H Nishikawa Y Hiasa T Muramatsu T Meguro N Inoue H Honda Y Hayashi S Miyazaki S Oshima T Honda N Shiode M Namura T Sone M Nobuyoshi T Kita K Mitsudo 2009 Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation Circulation 119 987 995 1:CAS:528:DC%2BD1MXhvFensbk%3D 10.1161/CIRCULATIONAHA. 108.808311 19204304
59. R Moreno C Fernandez R Hernandez F Alfonso DJ Angiolillo M Sabate J Escaned C Banuelos A Fernandez-Ortiz C Macaya 2005 Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies J Am Coll Cardiol 45 954 959 1:CAS:528:DC%2BD2MXit1Cju7w%3D 10.1016/j.jacc.2004.11. 065 15766835 (Pubitemid 40342825)
60. A Kaltoft LO Jensen M Maeng HH Tilsted P Thayssen M Bottcher JF Lassen LR Krusell K Rasmussen KN Hansen L Pedersen SP Johnsen HT Sorensen L Thuesen 2009 2-year clinical outcomes after implantation of sirolimus-eluting, paclitaxel-eluting, and bare-metal coronary stents: results from the WDHR (Western Denmark Heart Registry) J Am Coll Cardiol 53 658 664 1:CAS:528:DC%2BD1MXhvFGmurw%3D 10.1016/j.jacc.2008.09.058 19232897
61. MH Shishehbor SS Goel SR Kapadia DL Bhatt P Kelly RE Raymond JM Galla SJ Brener PL Whitlow SG Ellis 2008 Long-term impact of drug-eluting stents versus bare-metal stents on all-cause mortality J Am Coll Cardiol 52 1041 1048 1:CAS:528:DC%2BD1cXhtFekurfM 10.1016/j.jacc.2008.06.030 18848135
62. C Stettler S Allemann S Wandel A Kastrati MC Morice A Schomig ME Pfisterer GW Stone MB Leon JS de Lezo JJ Goy SJ Park M Sabate MJ Suttorp H Kelbaek C Spaulding M Menichelli P Vermeersch MT Dirksen P Cervinka M De Carlo A Erglis T Chechi P Ortolani MJ Schalij P Diem B Meier S Windecker P Juni 2008 Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis BMJ 337 a1331 10.1136/bmj.a1331 18757996
63. A Dibra K Tiroch S Schulz H Kelbaek C Spaulding GJ Laarman M Valgimigli E Di Lorenzo C Kaiser I Tierala J Mehilli G Campo L Thuesen MA Vink MJ Schalij R Violini A Schomig A Kastrati 2010 Drug-eluting stents in acute myocardial infarction: updated meta-analysis of randomized trials Clin Res Cardiol 99 345 357 1:CAS:528:DC%2BC3cXmsFSltL8%3D 10.1007/s00392-010-0133-y 20221617